Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations
Advanced Healthcare Materials · 2024-06 · 13 (16)
DOI: 10.1002/adhm.202303280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 15.03.2024. Verfasst von Valentina Andretto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Univ Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, Villeurbanne, F-69622, France. Hauptthemen laut MEDLINE: Hydrogels, Peptides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, ERA-NET TRANSCAN-3 initiative (JTC 2021), ARC, France: PerImmune project.
Abstract (Originalsprache)
Conventional therapies for inflammatory bowel diseases are mainly based on systemic treatments which cause side effects and toxicity over long‐term administration. Nanoparticles appear as a valid alternative to allow a preferential accumulation in inflamed tissues following oral administration while reducing systemic drug exposure. To increase their residence time in the inflamed intestine, the nanoparticles are here associated with a hydrogel matrix. A bioadhesive peptide‐based hydrogel is mixed with nanoemulsions, creating a hybrid lipid‐polymer nanocomposite. Mucopenetrating nanoemulsions of 100 nm are embedded in a scaffold constituted of the self‐assembling peptide hydrogel product PuraStat. The nanocomposite is fully characterized to study the impact of lipid particles in the hydrogel structure. Rheological measurements and circular dichroism analyses are performed to investigate the system's microstructure and physical properties. Biodistribution studies demonstrate that the nanocomposite acts as a depot in the stomach and facilitates the slow release of the nanoemulsions in the intestine. Efficacy studies upon oral administration of the drug‐loaded system show the improvement of the disease score in a mouse model of intestinal inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, Villeurbanne, F-69622, France.
- SATT, Ouest Valorisation, 14C Rue du Patis Tatelin, Renne, 35708, France.
- Department of Gastroenterology, Lyon Sud Hospital, Hospices Civil de Lyon and CIRI, Lyon, 69495, France.
- 3-D Matrix Europe SAS, Medical Technology, Caluire-et-Cuire, 69300, France.
- Univ Lyon, Université Claude Bernard Lyon 1, CNRS, ISA UMR 5280, 5 rue de la Doua, Villeurbanne, F-69100, France.
- Dept Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro 5, Rome, I-00185, Italy.
ORCID-Profile: Giovanna Lollo
Förderung
- Agence Nationale de la Recherche
- ERA-NET TRANSCAN-3 initiative (JTC 2021), ARC, France: PerImmune project
Zitieren
APA
Andretto, V., Rosso, A., Zilio, S., Sidi-Boumedine, J., Boschetti, G., Sankar, S., Buffier, M., Miele, A. E., Denis, M., Choffour, P. A., Briançon, S., Nancey, S., Kryza, D., & Lollo, G. (2024). Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations. Advanced Healthcare Materials, 13(16). https://doi.org/10.1002/adhm.202303280
Vancouver
Andretto V, Rosso A, Zilio S, Sidi-Boumedine J, Boschetti G, Sankar S, et al. Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations. Advanced Healthcare Materials. 2024;13(16). doi:10.1002/adhm.202303280
BibTeX
@article{Andretto2024,
author = {Andretto, Valentina and Rosso, Annalisa and Zilio, Serena and Sidi-Boumedine, Jacqueline and Boschetti, Gilles and Sankar, Sharanya and Buffier, Marie and Miele, Adriana Erica and Denis, Morgane and Choffour, Pierre-Antoine and Briançon, Stéphanie and Nancey, Stéphane and Kryza, David and Lollo, Giovanna},
title = {Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {16},
doi = {10.1002/adhm.202303280}
}
EUVIMED